Answers are grounded in this paper and cite their sources.
The subfamily Amaryllidoideae (Amaryllidaceae) consists of bulbous ornamental plants recognized as a rich source of alkaloids with diverse biological activities. Notably, these specialized metabolites have shown significant pharmacological potential, particularly in the symptomatic treatment of Alzheimer's disease. Within this subfamily of approximately 70 genera, Hippeastrum is extensively represented in Bolivia, exhibiting a high degree of diversity throughout the northern Andean region. The present study provides a detailed botanical and phytochemical characterization of Hippeastrum fragrantissimum , an endemic and threatened species from Bolivia, while simultaneously assessing its current conservation status. Specimens of H. fragrantissimum were analysed by gas chromatography-mass spectrometry (GC-MS). The results revealed 33 alkaloids and identified significant intraspecific chemical diversity. The alkaloid profile of the bulbs comprised 21 compounds, dominated by pretazettine- (61%), lycorine- (18%), and galanthamine-type (11%) scaffolds. In contrast, the leaf profile consisted of 15 alkaloids, primarily dominated by homolycorine- (60%) and galanthamine-type (20%) skeletons. Furthermore, the EIMS fragmentation pathways of dihydrolycorine derivatives were elucidated, leading to the tentative identification of 3 new Amaryllidaceae alkaloids. Given this unique biosynthetic profile and its vulnerable status, urgent conservation efforts are required.
No takes yet. Share an insight, caveat, or question.
Huaylla et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: